chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID+ 11/16/22.  Vaccination Status - pfizer x3 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider:  MD Admission Date: 11/16/2022 Discharge Date: 11/28/2022 Presenting Problem: Chronic combined systolic and diastolic heart failure (HCC)   Active Hospital Problems   Diagnosis Date Noted POA o Dysphagia 11/28/2022 Unknown o Nausea 11/19/2022 Unknown o Goals of care, counseling/discussion 08/23/2022 Yes o Nonischemic cardiomyopathy, EF 43%  07/11/2022 Yes o Chronic bilateral low back pain 11/07/2019 Yes o CKD (chronic kidney disease) stage 4, GFR 15-29 ml/min (HCC) 12/19/2017 Yes o Acute on chronic combined systolic and diastolic congestive heart failure (HCC) HOSPITAL COURSE: Patient is a 87 y.o. female known to Dr. with past and current medical history of combined systolic and diastolic heart failure, persistent Afib on eliquis, CAD, NICM EF 40-45%, AS s/p TAVR 8/9/2022, CKD stage 4, hypertension, RA, gout, and COPD. She was recently admitted to the observation unit 11/8-11/11 with decompensated heart failure. She received a few doses of IV diuresis and was transferred. Since being admitted to rehab she has not made any significant improvements and continued to decline. She was seen 11/15 for H2O follow up and was felt to be in decompensated heart failure, encouraged to go to the ED but declined. That night she hit her head (unclear details or memory of the event), but awoke with significant periorbital bruising which prompted her care facility to send her to the ED.    Head imaging negative for acute intracranial injury. She was initially admitted to ED observation with cardiology consult for concerns decompensated heart failure. Given concerns for volume overload with worsening renal function, Cardiology admitted patient for further optimization. Upon admission she was found to be COVID positive explaining much of her weakness and fatigue. She was diuresed with few doses of IV lasix, lasix then held over a weekend due to concern for AKI but CXR with worsening CHF and IV lasix resumed for few more days. She was diuresed to a weight of 80.3 kg and transitioned to an oral regimen of torsemide 40 mg BID. She did struggle with intermittent delirium in the hospital, repeat head CT unremarkable.    Noted to be anemia, iron studies consistent with iron deficiency anemia and received IV ferrlecit.    Palliative care was consulted for goals of care discussions. Code status updated to DNR. Will plan to follow outpatient. PT/OT/SLP consulted and all recommended she return \. Upon completion of COVID isolation she was transferred in stable condition, transport coordinated via care management.
scar tissue on the muscle where received the vaccine; received both doses at the end of December; arm pain where received the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SCAR (scar tissue on the muscle where received the vaccine), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received both doses at the end of December) and VACCINATION SITE PAIN (arm pain where received the vaccine) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided.  Concomitant products included MELATONIN and AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication.   In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SCAR (scar tissue on the muscle where received the vaccine), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received both doses at the end of December) and VACCINATION SITE PAIN (arm pain where received the vaccine). At the time of the report, VACCINATION SITE SCAR (scar tissue on the muscle where received the vaccine) and VACCINATION SITE PAIN (arm pain where received the vaccine) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received both doses at the end of December) had resolved.            No treatment information was provided.
Information has been received from a nurse from a physician's office concerning a woman in her 40's who on 14-DEC-2005 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine.  On 15-DEC-2005 the patient developed a local reaction characterized by a red, swollen arm.  The patient developed a local reaction characterized by a red, swollen arm.  The swelling was 3-4 inches in diameter around the injection site.  Unspecified medical attention was sought and at that the time of the report the patient had not recovered.  There was no product quality complaint involved.  Additional information has been requested.
Pt recv vax on 9/21/98; on same day pt exp fever (101.6), chills, body aches, headache
Fever, "throat closing" relieved w/ BENADRYL.  Rigoring, jaw locked. (L) axillary LAD/pain - nausea.
Information has been received from a 20 year old female consumer for GARDASIL, a Pregnancy Registry product, concerning her own experience, with "sulfa allergies" and with no pertinent medical history who on approximately 01-JUN-2010 was vaccinated with a first dose of GARDASIL (dose, route and Lot # not reported), "Three months from the second dose" on approximately 01-SEP-2010 was vaccinated with a second dose of GARDASIL (dose, route and Lot # not reported) and on "around first of December" approximately 01-DEC-2010 was vaccinated with a third dose of GARDASIL (dose, route and Lot # not reported). There was no concomitant medication. A pregnancy test was performed, which was positive. No adverse event reported. At the time of the report the patient had 15 days of gestation (LMP approximately on 01-NOV-2010; EDD on 08-AUG-2011). Follow-up information was received from a health professional who stated that the female patient on 10-DEC-2010, was vaccinated with the third 0.5 ml dose of GARDASIL (lot# 666595/0887Z). Her last menstrual period was stated to have been on 01-NOV-2010 and her estimated delivery date was reported to be 08-AUG-2011. Follow up information has been received via telephone call from the patient's grandmother who reported that the patient gave birth via cesarean section to a full term baby girl on 02-AUG-2011 (also reported as 02-AUG-2012). The baby girl was "perfectly healthy" and weighed 6lbs 8oz. The reporter stated that she believed the C-section was determined necessary in delivery because the baby "was carrying wrong". The pregnancy was reported to be normal otherwise and the grandmother stated that both the mom and the baby had no other complications after birth. Upon internal review C-section was considered to be an other important medical event. Additional information has been requested.
Myalgias, nausea, vomiting, weakness, SOB. Most likely secondary to his ESRD and missing dialysis on Saturday (1 day after receiving his 2nd dose of vaccine) but given the relation to his vaccination can not rule out vaccine adverse event.
Severe chills, fever, headache, diarrhea  Starting approx. 8:30 PM on 12/30/2020 until approx. 12:30 am 01/01/2021.
Left arm red, swollen and hot to touch.  Advised to apply cool compresses and cangue, Tylenol for discomfort.
Baby developing rash and hives on (R) cheek and some non-typical rash on the chest 15 minutes after given shots. Mild swelling in the injection site of varicella. Improved after given BENADRYL/Ibuprofen.
Awoke early morning with heavy sensation in chest. Noted abnormal premature beats, ie what I suspected were PVCs (I am a physician.) Baseline pulse rate is around 55; abnormal beats were about 2-3 per minute; primary episode lasted about 1.5 hrs. Couldn't reach PCP or my regular cardiologist so I contacted a friend who is a cardiologist with a specialty in electrophysiology. Described all my symptoms. He reviewed a nuclear stress test I had in April 2020, and said he did not think the event was either an MI or related to my booster. Abnormal beats persisted in decreasing frequency for 2 more hours.
Swollen upper arm, bruise (lasted 5 weeks), weak, dizziness, headache - would go away, bruises under fingernails.
This case was reported by the friend of a consumer and described the occurrence of a male subject of unspecified age not responding to therapy following vaccination with Havrix (GlaxoSmithKline). A physician or other health care professional has not verified this report. A physician or other health care professional has not verified this report. On an unspecified date the subject received unspecified dose of Havrix (unknown).  At an unspecified time after vaccination with Havrix, the subject was tested and showed to be not responding to therapy based on post vaccination antibody levels (results not reported). At the time of reporting the outcome of the event was unspecified. No further details expected.
PATIENT WAS COMPLAINING ABOUT NAUSEA AND VOMITING, PAINFUL ARM , SHAKINESS, DIZZINESS. NAUSEA STATED AROUND 230 PM ON 4/19/21 AND SHAKINESS, DIZZINESS PAINFUL ARM STARTED ON MORNING OF  4/20/21. VOMINTING ON 4/20/21 EARLY IN THE MORNING.
Seen at the clinic with 3 day hx of fever and injection site redness and swelling. Injections given on 8/13/2010. Mom applied warm soaks. Provider prescribed Cephalexin Monohydrate and Motrin with a re-evaluation appointment in 2 days for diagnosis of cellulitis.
Swelling of arm and lymph nodes on right side of the body.  These are still present at time of submission.
Since Janssen vaccine was administered,  the patient's genital herpes has been suppressed without daily use of valacyclovir.  This is 12 days at time of this report.  Prior to it, he will developed vesicles in clusters in the same area of the penis as soon as two days with out valacyclovir.  Thought  this is not an " adverse" effects is an unintended side effect of the vaccine.
After the second covid moderna vaccine. Could not move for 1-2 days could not even lift her head up. Per pt was very sudden and very intense.  Additionally pt tested positive for Covid 2.5 months after being  fully vaccinated . Pt had fatigue and  lost sense of smell and did at two at home covid test both tests were positive did not get reported as positive test to CDC
Swelling of right thigh noted approx 24 hours after DTaP injection. Swelling from upper thigh to upper knee.
This spontaneous report as received from a Medical assistant referring to unspecified patients of unknown genders. No information regarding the patients' medical history, concurrent conditions or concomitant therapies was provided. On an unknown date, the patients were vaccinated with improperly stored dose of GARDASIL 9 which had a lot number M037770 with expiration date on 01-JUN-2019 (strength and route of administration were not reported) for prophylaxis, however no adverse effects reported. It was reported that the vaccines were exposed to temperature of 52 grades F (Fahrenheit) for a time frame of 12 hours. There were no previous temperature excursions for vaccines.  The temperature excursion was recorded by a data logger. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1612USA009885: US-009507513-1703USA006986: US-009507513-1703USA006984: US-009507513-1702USA009836:
Patient had a swollen area around the shot area. The swollen area was swollen more than usual post-shot swelling. She also stated that the area was itching. Pt reported no problems breathing or any other signs of allergic reaction. This occurred approximately 4 hours after shot. I advised patient to apply a cold compress to the area, take ibuprofen, and BENADRYL. Patient had same reaction last year and recovered in a few days with no other issues.
Patient c/o shortness of breath and dizziness at 1145, patient transported to ED at 1150 via w/c. VS stable.
Nausea, headaches, body aches, poor appetite, injection site red and swollen started the day after vaccination
Client and guardian came in to clinic requesting a flu shot. Front desk staff had client's guardian complete consent form for a flu vaccine and offered VIS form. Guardian declined. Nurse brought client back into room with guardian and confirmed name and DOB. Writer confirmed they were here for a flu shot, went over screening questions and administered vaccine. After vaccine administered, client and guardian inquired that they did receive the COVID Vaccine. RN informed them that they did not receive a COVID Vaccine, that they received a flu vaccine. Client states he already had a flu vaccine. RN went over error with client and guardian and did not administer COVID Vaccine due to facility not being ready. Did refer client and guardian to other area clinic for COVID vaccine.
pt recv vax 21DEC95 & pt exp stiffness, pain, tenderness, swelling, heat & redness @ the inj site that spread to just above elbow;tx w/heat packs & APAP;
After I received the vaccine, my arm swelled for about three days and hurt. In 01/2023, I began having spasms in my back and I thought I was constipated. I drank lots of fluids and eventually felt better. I developed a cough that lasted for several weeks. In 04/2023, I had a very bad sore and red throat. I tested negative for COVID-19. I have had a lot of nasal congestion and drainage. As of today, I continue to have random days of my throat burning and congestion.
Did not feel patient received full dose; He realized the needle separated from syringe; Patient felt a spray on her arm; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of UNDERDOSE (Did not feel patient received full dose), DEVICE CONNECTION ISSUE (He realized the needle separated from syringe) and ACCIDENTAL EXPOSURE TO PRODUCT (Patient felt a spray on her arm) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038a21a) for COVID-19 immunisation.     The patient's past medical history included No adverse event (No reported medical history.).    On 19-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 19-Mar-2021, the patient experienced UNDERDOSE (Did not feel patient received full dose), DEVICE CONNECTION ISSUE (He realized the needle separated from syringe) and ACCIDENTAL EXPOSURE TO PRODUCT (Patient felt a spray on her arm). On 19-Mar-2021, UNDERDOSE (Did not feel patient received full dose), DEVICE CONNECTION ISSUE (He realized the needle separated from syringe) and ACCIDENTAL EXPOSURE TO PRODUCT (Patient felt a spray on her arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Period very very late for jam and just dark brown spotting very end of jan beginning of feb. unusual
She developed new onset elevated BP, systolic BP 199 with epistaxis, required ER visit and tx for epistaxis...BP slowly normalized
Mother describes her son woke up 8/4/05 with 3 "red dots" on upper eyelid, appears "like maybe it could be acne" and eye slightly swollen.  No redness from sclera or drainage from the eye.  Eye washed and seems to have helped. He was not seen by his family doctor. Swelling lasted about 3 days.  Mother denies that he has a fever or other symptoms.
Case number PHEH2016US031908, is a combined initial and follow up spontaneous report received from a pharmacist (who is patient's sister) on 05 Dec 2016 and 09 Dec 2016. This report refers to a female patient. Past medical history and concomitant medications were not reported. She was vaccinated with INN (unknown manufacturer, batch number: not reported) on an unknown date 15 to 20 years ago (details unspecified). After vaccination, she developed rash on an unknown date. It was reported that she was recently administered with FLUCELVAX with no issues. The outcome of rash was unknown. The seriousness and causality of the event were not reported. The case was considered lost to follow up at initial.
Pt had Pfizer Covid vaccines in the past.  I reviewed her vaccine card with her.  I discussed Pfizer bivalent and pointed this out on the literature.  Pt verbalized understanding of teaching.   I did not see on her paper that she had checked Moderna Bivalent this time instead of the Pfizer Bivalent.  Pt received Pfizer Bivalent and I saw the error when charting the lot #.   I explained the error.  Pt was not happy as she "wanted the superior vaccine" this time instead of Pfizer.  I aknowledged my error, apologized, and explained that I would make a VAERS report.  Pt waited the observation time of 15 min.  No adverse effects from vaccine while in the office.
Red immediately after immunization, hard to touch, itchy. Patient applied rubbing alcohol. Now still red, slightly indurated 5.5 x 10 cm. Patient prescribed Claritin 10 mg QD and Westcort Cream to be applied TID.
Pfizer Covid vaccine booster was administered to a 17 year old male. Spoke to patient, he stated he has a sore arm from the shot, but experiencing no other symptoms.
p/vax pt was limping;this progressed into severe muscle weakness, forcing pt to stop & rest between patients;1998 pt gave up practice altogether because of the severe muscle weakness;pt can no longer drive car nor practice dentistry;
Itching, red, swelling, rash-like at injection site (very similar to a bug bite) 10 days after 1st shot.
left arm pain at injection site, barely able to lift arm above shoulder without pain for first 2 days.  2 weeks later, still painful at injection site and general left deltoid area.  no pain to touch, just with movements.  pain with certain range of motion
I was startled by something at work and began to have serious chest paint,  Tightness in my teeth, my back hurt, heart beat out of control.   I measured it with my phone and it was 200bpm.  I got a friend to take me to the hospital.  When admitted, it was down to 180bpm and in AFIB.  I was held overnight.  Next morning not much better, did a cardioversion procedure and things stabilized.  Have been fine since with only minor almost singular heart fluttering
Experienced rapid heartbeat and very high blood pressure, difficulty breathing, dizziness and felt very weak shortly after receiving the Shingles vaccine.  The pharmacist called an ambulance.  Was treated by the paramedics (or EMTs, not sure of their job title), and taken via ambulance to Hospital.  Received additional treatment at Hospital.  Then felt a lot better, but was experiencing a headache.  Was released from Hospital nearly a couple of hours later, and was directed to pick up a prescription from pharmacy (methylprednisolone).
Ear fullness and tinnitus in both ears.  headache, loss of balance, hearing fluctuation,  dizziness, exhaustion, confusion, and body aches.
Pt received vaccine 3/18/2008 - came to office on 3/20/2008 with local erythema/edema to area.
pt recv vax 7JUN95 & 8JUN95 pt devel 5 lesions; No further details were provided;
A nurse reported his 19 month old son received his 1st injection of Prevnar on an unspecified date. Soon afterward, the child developed injection site redness. Two months following vaccination, the child had a blood test that revealed hyperglycemia and a diagnosis of type I diabetes was made. The child was hospitalized and required unspecified intervention. The event is now being managed with insulin.
Broken Hip; Fall; A report was received from a consumer who was also a 73-year old, male patient who had a fall and broke his hip.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 25 JAN 2021, the patient received the first of two planned doses of mRNA-1273 (Batch number not provided) intramuscularly for prophylaxis of COVID-19 infection.    On 20 FEB 2021 the patient had a fall and broke his hip. The patient received surgery to repair the injury and was prescribed pain medications.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the events was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event of fall, a causal relationship cannot be excluded and the event of hip fracture is assessed as unlikely related to mRNA-1273.
rash on the front of her legs; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: not reported, Expiry date: not reported), via an unspecified route of administration on 10Feb2021 as dose 1, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced rash on the front of her legs. The patient was using Benadryl, for 3 days. Therapeutic measures were taken as a result of rash on the front of her legs. The outcome of the event was unknown.   Information about lot/ batch number has been requested.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. Follow-up attempts completed. No further information is expected.
Fluttering in the chest Nausea, Emesis Chest Tightness Shortness of Breath Lightheadedness
Fever; Cough; Fatigue; This is a spontaneous report from a contactable consumer (patient). A 22-year-old (non-pregnant) female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Batch/Lot number: EN6207) via unspecified route of administration in the left arm on 20Mar2021 16:30 (at the age of 22-year-old) at dose 2, single for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: EN6200) via an unspecified route of administration in the right arm on 27Feb2021 (at the age of 22-year-old) at a dose 1, single for COVID-19 immunisation. Prior to vaccination, patient had no symptoms associated with COVID-19. The patient was not enrolled in clinical trial. Since the vaccination, the patient had not been tested for COVID-19. On 21Mar2021, the patient experienced fever, cough and fatigue. The patient did not receive treatment for the reported events. The clinical outcome of fever, cough and fatigue was not resolved.   No follow-up attempts are needed. No further information is expected.  Amendment (30Jun2021): This follow-up report is being submitted to amend previously reported information: The age and unit for 'Historical Vaccine' update as 22 years. Narrative 'Since the vaccination, the patient had not tested positive for COVID-19' was updated as 'Since the vaccination, the patient had not been tested for COVID-19'.
On Nov 28th, patient reported that his arm is still sore and he has pain lifting arm above the shoulder level.  Deep ache all the time since the vaccinations.